Bristol-Myers Squibb pays $14m settlement over gifts to Chinese health-care providers
The charges against the New York-based pharmaceutical company were brought by the U.S. Securities and Exchange Commission under the FCPA's books and records and internal controls provisions.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10